Therapeutics: TOR signaling pathway regulator (TIPRL); protein phosphatase 2 regulatory subunit A α (PPP2R1A)

Cancer

INDICATION: Endometrial cancer

Cell culture studies suggest inhibiting TIPRL could

Read the full 94 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE